Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

被引:207
作者
Hofmann, H
Geier, M
Marzi, A
Krumbiegel, M
Peipp, M
Fey, GH
Gramberg, T
Pöhlmann, S
机构
[1] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Chair Genet, D-91054 Erlangen, Germany
关键词
severe acute respiratory syndrome; coronavirus; angiotensin converting enzyme 2;
D O I
10.1016/j.bbrc.2004.05.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The angiotensin converting enzyme 2 (ACE2) has been identified as a receptor for the severe acute respiratory syndrome associated coronavirus (SARS-CoV). Here we show that ACE2 expression on cell lines correlates with susceptibility to SARS-CoV S-driven infection, suggesting that ACE2 is a major receptor for SARS-CoV. The soluble ectodomain of ACE2 specifically abrogated S-mediated infection and might therefore be exploited for the generation of inhibitors. Deletion of a major portion of the cytoplasmic domain of ACE2 had no effect on S-driven infection, indicating that this domain is not important for receptor function. Our results point to a central role of ACE2 in SARS-CoV infection and suggest a minor contribution of the cytoplasmic domain to receptor function. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1216 / 1221
页数:6
相关论文
共 23 条
  • [1] Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor
    Babcock, GJ
    Esshaki, DJ
    Thomas, WD
    Ambrosino, DM
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (09) : 4552 - 4560
  • [2] VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES
    CONNOR, RI
    CHEN, BK
    CHOE, S
    LANDAU, NR
    [J]. VIROLOGY, 1995, 206 (02) : 935 - 944
  • [3] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976
  • [4] Eickmann M, 2003, SCIENCE, V302, P1504
  • [5] Coronavirus spike proteins in viral entry and pathogenesis
    Gallagher, TM
    Buchmeier, MJ
    [J]. VIROLOGY, 2001, 279 (02) : 371 - 374
  • [6] S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients
    Hofmann, H
    Hattermann, K
    Marzi, A
    Gramberg, T
    Geier, M
    Krumbiegel, M
    Kuate, S
    Überla, K
    Niedrig, M
    Pöhlmann, S
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (12) : 6134 - 6142
  • [7] A novel coronavirus associated with severe acute respiratory syndrome
    Ksiazek, TG
    Erdman, D
    Goldsmith, CS
    Zaki, SR
    Peret, T
    Emery, S
    Tong, SX
    Urbani, C
    Comer, JA
    Lim, W
    Rollin, PE
    Dowell, SF
    Ling, AE
    Humphrey, CD
    Shieh, WJ
    Guarner, J
    Paddock, CD
    Rota, P
    Fields, B
    DeRisi, J
    Yang, JY
    Cox, N
    Hughes, JM
    LeDuc, JW
    Bellini, WJ
    Anderson, LJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1953 - 1966
  • [8] Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
    Li, WH
    Moore, MJ
    Vasilieva, N
    Sui, JH
    Wong, SK
    Berne, MA
    Somasundaran, M
    Sullivan, JL
    Luzuriaga, K
    Greenough, TC
    Choe, H
    Farzan, M
    [J]. NATURE, 2003, 426 (6965) : 450 - 454
  • [9] The genome sequence of the SARS-associated coronavirus
    Marra, MA
    Jones, SJM
    Astell, CR
    Holt, RA
    Brooks-Wilson, A
    Butterfield, YSN
    Khattra, J
    Asano, JK
    Barber, SA
    Chan, SY
    Cloutier, A
    Coughlin, SM
    Freeman, D
    Girn, N
    Griffith, OL
    Leach, SR
    Mayo, M
    McDonald, H
    Montgomery, SB
    Pandoh, PK
    Petrescu, AS
    Robertson, AG
    Schein, JE
    Siddiqui, A
    Smailus, DE
    Stott, JE
    Yang, GS
    Plummer, F
    Andonov, A
    Artsob, H
    Bastien, N
    Bernard, K
    Booth, TF
    Bowness, D
    Czub, M
    Drebot, M
    Fernando, L
    Flick, R
    Garbutt, M
    Gray, M
    Grolla, A
    Jones, S
    Feldmann, H
    Meyers, A
    Kabani, A
    Li, Y
    Normand, S
    Stroher, U
    Tipples, GA
    Tyler, S
    [J]. SCIENCE, 2003, 300 (5624) : 1399 - 1404
  • [10] Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
    Martin, L
    Stricher, F
    Missé, D
    Sironi, F
    Pugnière, M
    Barthe, P
    Prado-Gotor, R
    Freulon, I
    Magne, X
    Roumestand, C
    Ménez, A
    Lusso, P
    Veas, F
    Vita, C
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (01) : 71 - 76